Avenir Wellness Solutions, INC

Nancy Duitch, CEO of Avenir Wellness Solutions, has voluntarily resigned, effective March 1, 2025, and Joel Bennett, the CFO, will serve as temporary CEO.

Avenir Wellness Solutions has reached a settlement with Ionic Ventures, converting a portion of its debt into equity, extinguishing the remaining debt for a new note, and resolving pending litigation.

Avenir Wellness Solutions, Inc. has entered into a Securities Purchase Agreement to issue bridge notes totaling up to $471,900, including an initial $121,900, to 1800 Diagonal Lending LLC.

Avenir Wellness Solutions will restate financial statements for 2021 and parts of 2022 due to errors in earnings per share calculations.

Avenir Wellness Solutions will restate financial statements for 2021 and part of 2022 due to errors in earnings per share calculations.

Avenir Wellness Solutions has entered into a secured loan agreement with its CEO, Nancy Duitch, for up to $250,000, with an initial draw of $39,000.

Avenir Wellness Solutions experienced a significant decrease in revenue during the third quarter of 2024, alongside reduced operating expenses and a net loss.

Avenir Wellness Solutions has filed an amended quarterly report to correct an error in the calculation of weighted average shares outstanding, impacting earnings per share for the first quarter of 2022.

Avenir Wellness Solutions, formerly CURE Pharmaceutical Holding Corp., has filed an amended quarterly report to restate its earnings per share for the nine months ended September 30, 2021, due to an error in calculating weighted average shares outstanding.

Avenir Wellness Solutions has filed an amended 10-Q report to restate its earnings per share for the six months ended June 30, 2021, due to an error in the calculation of weighted average shares outstanding.

Avenir Wellness Solutions reported a decrease in revenue for the second quarter of 2024, alongside reduced operating expenses and a net loss.

Avenir Wellness Solutions experienced a significant decrease in revenue during the first quarter of 2024, alongside a net loss, as detailed in their recent 10-Q filing.

Avenir Wellness Solutions, Inc. released its 2023 annual report, highlighting a strategic shift towards nutraceuticals and a decrease in revenue, alongside efforts to manage operating costs.

Ionic Ventures, LLC and its affiliated reporting persons have disclosed a 9.5% beneficial ownership stake in Avenir Wellness Solutions, Inc., totaling 8,306,000 shares of common stock, following a recent share issuance.